In this regard, the presence of multilineage involvement of haematopoiesis by the KIT D816V mutation, particularly in the context of a multi-mutated disease in which additional myeloid-neoplasm-associated genes other than KIT are also mutated, emerges as the altered genetic background that might contribute to explain malignant transformation of SM. This evidence concerns the gene KIT and systemic mastocytosis.